16
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

New antiepileptic drugs

Overcoming the limitations of traditional therapy

, MD & , MD
Pages 147-162 | Published online: 30 Jun 2015
 

PREVIEW

Approval of several antiepileptic drugs since 1993 has implications for primary care physicians who are treating epileptic patients. How do these new agents differ from standard therapy? What advantages do they offer? The authors of this article take a comprehensive look at five new agents—felbamate, fosphenytoin, gabapentin, lamotrigine, and topiramate.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.